News

Australia is facing critical issues relating to the supply of EpiPen® Jr, with ASCIA and Allergy & Anaphylaxis Australia (A&AA) having been notified that from 5 December 2019, there is no available EpiPen® Jr stock in the country. In this…

Public hearings have been held in Canberra, Melbourne and Sydney as part of the Parliamentary inquiry into allergies and anaphylaxis. Transcripts of these sessions are now available. Professor Brendan Murphy, Chief Medical Officer at the Department of Health, and Dr…

Researchers have tested the levels of gluten cross-contact caused by sharing kitchen equipment when preparing gluten free food. The details of their study have been published in an Open Access paper. Three scenarios were tested in a simulated home kitchen environment.…

Nanoparticle technology that has taken decades to develop has shown promising results in a Phase II trial that indicates it may help people with coeliac disease to safely eat gluten. For the Phase II study, treatment was tested against a…

Japan’s Consumer Affairs Agency has added almonds to the list of allergenic foods that it recommends be listed on food labels if present, and walnut has been designated as a food subject to mandatory labelling. The changes come following the…

Accurate food allergen labelling relies on evidence-based risk assessment. This process helps predict whether or not the amount of an allergen that may be present in a product due to cross-contact could pose a danger to someone with food allergy.…